financetom
Business
financetom
/
Business
/
WestBridge Capital and Rakesh Jhunjhunwala acquire Star Health
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
WestBridge Capital and Rakesh Jhunjhunwala acquire Star Health
Aug 18, 2018 7:04 AM

India's largest health insurance company in terms of profits and premium, Star Health is being acquired for a billion dollars by Rakesh Jhunjhunwala and a consortium led by WestBridge Capital. Yash Jain broke this story on July 20th.

After 18 month long bidding, we finally have a buyer for Star Health Insurance. A consortium of Rakesh Jhunjhunwala along with WestBridge Capital have been selected as the final buyer for Start Health Insurance and sources tell us that it was a race between this particular consortium with ICICI Lombard General Insurance.

ICICI Lombard General Insurance had placed a bid amount of approximately Rs 5,800 crore whereas the consortium led by Rakesh Jhunjhunwala had submitted a bid amount of approximately Rs 6,500 crore. So the valuation aspect of this particular transaction went in favour of the consortium led by Rakesh Jhunjhunwala.

- Rakesh Jhunjhunwala will be a promoter of Start Health with 35 percent stake in the company.

- Safecrop Holdings will be the new owner of Start Health

- Safecrop Holdings comprises of WestBridge AIF, Rakesh Jhunjhunwala, Madison Capital

First Published:Aug 18, 2018 4:04 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IGC Pharma Says Molecule IGC-1A Identified as Potential GLP-1 Agonist
IGC Pharma Says Molecule IGC-1A Identified as Potential GLP-1 Agonist
Aug 20, 2024
09:16 AM EDT, 08/20/2024 (MT Newswires) -- IGC Pharma ( IGC ) said Tuesday that its artificial intelligence modeling found molecule IGC-1A to be a potential glucagon-like peptide-1, or GLP-1, agonist. With this discovery, IGC Pharma ( IGC ) said it is positioned to potentially expand its drug portfolio to metabolic disorders and weight loss. GLP-1 agonists are known to...
Meta Platforms' Revised Rules on Advertising Data Use Accepted by UK Competition Regulator
Meta Platforms' Revised Rules on Advertising Data Use Accepted by UK Competition Regulator
Aug 20, 2024
09:17 AM EDT, 08/20/2024 (MT Newswires) -- Meta Platforms' ( META ) changes to rules on the way it uses data of advertising customers have been accepted by the UK's Competition and Markets Authority, the regulator said Tuesday. The CMA said that under the new approach that Meta plans to adopt, all advertisers can keep the ability to place advertisements...
Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday
Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday
Aug 20, 2024
09:15 AM EDT, 08/20/2024 (MT Newswires) -- Consumer stocks were mixed pre-bell Tuesday as the Consumer Staples Select Sector SPDR Fund ( XLP ) was advancing 0.02% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) was recently down 0.01%. Vipshop Holdings ( VIPS ) shares fell by nearly 7% after it reported lower Q2 non-GAAP earnings and...
Stellantis to Delay Reopening of Belvidere Assembly Plant
Stellantis to Delay Reopening of Belvidere Assembly Plant
Aug 20, 2024
08:40 AM EDT, 08/20/2024 (MT Newswires) -- Stellantis NV ( STLA ) has notified the United Auto Workers union that plans to reopen the Belvidere assembly plant in Illinois will be delayed, but it remains committed to the project, the company said Tuesday. To ensure the Company's future competitiveness and sustainability, which are necessary to preserve U.S. manufacturing jobs, it...
Copyright 2023-2025 - www.financetom.com All Rights Reserved